Full text is available at the source.
Abstract
The 2026 European Society of Cardiology Guidelines for managing cardiovascular disease and chronic kidney disease may not fully address the complexities faced by older adults.
- Chronic conditions like frailty, sarcopenia, and cognitive impairment could significantly affect treatment outcomes in older individuals.
- Traditional metrics such as age and kidney function may overlook key aspects of clinical heterogeneity in this population.
- Advanced age alone should not be a reason to deny evidence-based treatments to older adults who remain functionally capable.
- A proposed framework, STAMP-F, aims to incorporate factors related to frailty and future healthspan into clinical decision-making.
- Simple assessment tools like the Clinical Frailty Scale and gait speed may facilitate the evaluation of these additional health aspects.
- Further prospective studies are necessary to evaluate the effectiveness of this approach on clinical decisions and patient outcomes.
Simplified